Opus Genetics director granted 24,367 RSUs

Gallagher Cam reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Gallagher Cam reported acquisition or exercise transactions in this Form 4 filing.

Opus Genetics, Inc. director Cam Gallagher reported an equity compensation grant and updated share holdings. He received 24,367 shares of Common Stock as a grant of restricted stock units at $0.0000 per share, which vest upon the earlier of one year from grant or the day before the next annual stockholder meeting, subject to continued service. Following this grant, he directly holds 2,015,797 Common Stock shares. A separate holding entry shows 83,000 Common Stock shares held indirectly as custodian for a minor child under the Uniform Transfer to Minors Act, for which he disclaims beneficial ownership except to any pecuniary interest.

Insider Trade Summary

Grant/Award: 24,367 shares

Grant/Award 2 txns

Insider Gallagher Cam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	24,367	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,015,797 shares (Direct); Common Stock — 83,000 shares (Indirect, By Garret Gallagher - Custodian UTMA/UGMA)

Footnotes (2)

1. F1. Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
2. F2. These securities are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Key Figures

RSU grant size: 24,367 shares Grant price: $0.0000 per share Direct holdings after grant: 2,015,797 shares +2 more

5 metrics

RSU grant size 24,367 shares Restricted stock units of Common Stock granted to director

Grant price $0.0000 per share Price per share for the restricted stock unit grant

Direct holdings after grant 2,015,797 shares Common Stock directly owned following the transaction

Indirect custodial holdings 83,000 shares Shares held as custodian for a minor child under UTMA

Vesting condition Earlier of 1 year or pre-next annual meeting Vesting schedule for the restricted stock units, service-based

Key Terms

restricted stock units, Uniform Transfer to Minors Act, pecuniary interest

3 terms

restricted stock units financial

"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Uniform Transfer to Minors Act financial

"held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act"

pecuniary interest financial

"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cam Gallagher report for Opus Genetics (IRD)?

Cam Gallagher reported receiving a grant of 24,367 Opus Genetics common shares as restricted stock units at $0.0000 per share. These units are equity compensation rather than an open-market purchase, reflecting a non-cash award tied to his service as a director.

How many Opus Genetics (IRD) shares does Cam Gallagher hold after this Form 4?

After the reported grant, Cam Gallagher directly holds 2,015,797 shares of Opus Genetics common stock. The Form 4 also shows an additional 83,000 shares held indirectly as custodian for a minor child under the Uniform Transfer to Minors Act.

How do the restricted stock units granted to Cam Gallagher vest at Opus Genetics (IRD)?

The 24,367 restricted stock units vest on the earlier of the one-year anniversary of the grant date or the day before Opus Genetics’ next annual stockholder meeting. Vesting is conditioned on Gallagher’s continued service through the applicable vesting date.

Were Cam Gallagher’s Opus Genetics (IRD) shares bought on the open market?

No, the reported 24,367 shares were received as a grant of restricted stock units at a price of $0.0000 per share. This represents equity compensation granted by the company rather than an open-market purchase or sale transaction.

What does the custodian entry mean in Cam Gallagher’s Opus Genetics (IRD) holdings?

The Form 4 lists 83,000 Opus Genetics shares held indirectly by Gallagher as custodian for a minor under the Uniform Transfer to Minors Act. He disclaims beneficial ownership of these shares except for any pecuniary interest he may have in them.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/22/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gallagher Cam

(Last) (First) (Middle)

C/O OPUS GENETICS, INC.

8 DAVIS DRIVE, SUITE 220

(Street)

DURHAM NORTH CAROLINA 27713

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Opus Genetics, Inc. [ IRD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/20/2026		A		24,367(1)	A	$0	2,015,797	D
Common Stock								83,000	I	By Garret Gallagher - Custodian UTMA/UGMA(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

2. These securities are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

	/s/ Amy Rabourn, by Power of Attorney	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)